Evolent Health, Inc. (EVH)

4.9 USD+2.73%close 2026-11-13Industrials
Gurus hold—none of the tracked superinvestors
Net buying (quarter)—latest quarter, superinvestors
Market Cap$554.2M52 Week Range: 2.17 – 6.19
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.LossEPS -4.54
The live quote provider is unreachable; the last known close is shown.

Evolent Health, Inc. (EVH) is not among the 30 most-held stocks of the tracked superinvestor set. Price 4.90 USD; market cap $554.2M.

Price & valuation

Prev Close4.77
Open—
Day Range—
52 Week Range2.17 – 6.19
Volume—
Avg Volume (3M)—
Market Cap$554.2MSEC 10-Q, 10/30/2026
BetaVolatility vs the market. Above 1: swings harder than the index.0.862 years, weekly, vs SPY
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.LossSEC 10-Q, 09/30/2026
EPS (TTM)Annual net profit per share.-4.54SEC 10-Q, 09/30/2026
Dividend YieldAnnual dividend over share price.—

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

About

SectorIndustrials
Industry—
Employees—
Website—

Frequently Asked Questions

Which superinvestors own EVH?

Evolent Health, Inc. (EVH) is not among the 30 most-held stocks of the tracked superinvestor set.

Is institutional sentiment on EVH bullish or bearish?

EVH is not among the 30 most-held stocks of the superinvestor set, so net buyer/seller counts are not computed for it.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.